|
|||||
|
|
Comments on the report of the EFNS task force on IFN-beta antibodies in multiple sclerosis |
|
| Authors: | M. S. Freedman |
| Affiliation: | University of Ottawa, Department of Medicine (Neurology), The Ottawa Hospital-General Campus |
| Abstract: | |
| Keywords: | controversy guideline interferon multiple sclerosis neutralizing antibody treatment |